baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Soc. Generale Knock-Out PHARM/ DE000SY1UQ51 /

7/29/2024 10:21:44 AM	Chg.0.000	Bid10:00:36 PM	Ask10:00:36 PM	Underlying	Strike price	Expiration date	Option type
0.130EUR	0.00%	- Bid Size: -	- Ask Size: -	Pharming Group	0.8792 EUR	12/31/2078	Put

GlobeNewswire 6/3 Pharming Group to participate in June investor conferences

GlobeNewswire 5/21 Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders

GlobeNewswire 5/20 Pharming Group to participate in May investor conference

GlobeNewswire 5/8 Pharming Group reports first quarter 2024 financial results and provides business update

GlobeNewswire 4/24 Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 20...

GlobeNewswire 4/8 Pharming announces completion of enrollment in pediatric clinical trial of leniolisib

GlobeNewswire 4/3 Pharming Group to participate in April investor conferences

GlobeNewswire 3/14 Pharming Group reports fourth quarter and full year 2023 financial results

GlobeNewswire 2/29 Pharming Group to report fourth quarter and full year 2023 financial results on March 14

GlobeNewswire 2/8 Pharming Group to participate in February investor conferences

GlobeNewswire 1/8 Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update

GlobeNewswire 12/13/2023 Pharming Group announces development plans for leniolisib for additional primary immunodeficiencies ...

GlobeNewswire 11/21/2023 Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years fo...

GlobeNewswire 11/13/2023 Orchard Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Business Acc...

GlobeNewswire 11/1/2023 Pharming Group to participate in November investor conferences

GlobeNewswire 10/26/2023 Pharming Group reports third quarter 2023 financial results

GlobeNewswire 10/12/2023 Pharming Group to report third quarter 2023 financial results on October 26

GlobeNewswire 9/25/2023 Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders

GlobeNewswire 1/10/2022 Orchard Therapeutics Announces Recent Commercial and Regulatory Progress for Late-stage HSC Gene The...

GlobeNewswire 11/4/2021 Orchard Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Business Upd...

GlobeNewswire 8/4/2021 Orchard Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Business Up...

GlobeNewswire 7/29/2021 Oncorus Expands its Board with Appointment of Barbara Yanni

GlobeNewswire 7/1/2021 Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo ...

GlobeNewswire 1/20/2021 Longboard Pharmaceuticals Appoints Phillip Schneider and Paul Sekhri to Board of Directors

GlobeNewswire 1/9/2019 Global Hereditary Hematological Disorders Drug Development Pipeline Review 2018

Soc. Generale Knock-Out PHARM/ DE000SY1UQ51 /

If you wish to receive reply to your feedback, please provide your email address.